Point-of-care testing for infectious diseases: Past, present, and future

Journal of Clinical Microbiology

Volumn 55, Issue 8, 2017, Pages 2313-2320

  Kozel, Thomas R ^a,b   Burnham Marusich, Amanda R ^a,b  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b DxDiscovery Inc ^*  (United States)

Author keywords

Infectious disease; Lateral flow immunoassay; Molecular diagnostic; Point of care; Rapid tests

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPARIN BINDING PROTEIN; PROCALCITONIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIBODY DETECTION; BIOTECHNOLOGY; BORDETELLA PERTUSSIS; COHORT ANALYSIS; CRYPTOCOCCAL MENINGITIS; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOASSAY; INFLUENZA A; INFLUENZA B; LATERAL FLOW IMMUNOASSAY; LONGITUDINAL STUDY; MALARIA; MICROARRAY ANALYSIS; MICROFLUIDICS; MOLECULAR DIAGNOSTICS; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; POINT OF CARE TESTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL PHARYNGITIS; STREPTOCOCCUS AGALACTIAE; COMMUNICABLE DISEASE; IMMUNOAFFINITY CHROMATOGRAPHY; MOLECULAR DIAGNOSIS; PROCEDURES; TRENDS; UTILIZATION;

COMMUNICABLE DISEASES; HUMANS; IMMUNOCHROMATOGRAPHY; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE TESTING;

EID: 85026235164     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00476-17     Document Type: Review

References (38)

1. Dochez AR, Avery OT. 1917. The elaboration of specific soluble substance by pneumococcus during growth. J Exp Med 26:477-493. https:// doi.org/10.1084/jem.26.4.477.
2. Yalow RS, Berson SA. 1960. Immunoassay of endogenous plasma insulin in man. J Clin Invest 39:1157-1175. https://doi.org/10.1172/JCI104130.
3. Engvall E, Perlmann P. 1971. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8:871-874.
4. Van Weemen BK, Schuurs AH. 1971. Immunoassay using antigenenzyme conjugates. FEBS Lett 15:232-236. https://doi.org/10.1016/0014-5793(71)80319-8.
5. Glad C, Grubb AO. 1981. Immunocapillarymigration with enzymelabeled antibodies: rapid quantification of C-reactive protein in human plasma. Anal Biochem 116:335-340. https://doi.org/10.1016/0003-2697(81)90367-5.
6. Leuvering JH, Thal PJ, van der Waart M, Schuurs AH. 1980. Sol particle immunoassay (SPIA). J Immunoassay 1:77-91. https://doi.org/10.1080/ 01971528008055777.
7. Campbell RL, Wagner DB, O'Connell JP. October 1987. Solid phase assay with visual readout. US patent 4,703,017.
8. Rosenstein RW, Bloomster TG. August 1989. Solid phase assay employing capillary flow. US patent 4,855,240.
9. May K, Prior ME, Richards I. April 1997. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents. US patent 5,622,871.
10. Centers for Medicare and Medicaid Services. Tests waived granted status under CLIA. Centers for Medicare and Medicaid Services, Baltimore, MD. https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/ Downloads/waivetbl.pdf. Accessed 24 January 2017.
11. FDA. 2014. CLIA categorizations. FDA, Washington, DC. https://www.fda .gov/MedicalDevices/DeviceRegulationandGuidance/IVDRegulatory Assistance/ucm393229.htm. Accessed 9 May 2017.
12. Bloomfield N, Gordon MA, Elmendorf DF, Jr. 1963. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc Soc Exp Biol Med 114:64-67. https://doi.org/10.3181/00379727-114-28586.
13. Jarvis JN, Percival A, Bauman S, Pelfrey J, Meintjes G, Williams GN, Longley N, Harrison TS, Kozel TR. 2011. Evaluation of a novel point-ofcare cryptococcal antigen test on serum, plasma, and urine from pa-tients with HIV-associated cryptococcal meningitis. Clin Infect Dis 53: 1019-1023. https://doi.org/10.1093/cid/cir613.
14. World Health Organization. 2011. Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2011/9789241502979-eng.pdf.
15. Williams DA, Kiiza T, Kwizera R, Kiggundu R, Velamakanni S, Meya DB, Rhein J, Boulware DR. 2015. Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study. Clin Infect Dis 61:464-467. https://doi.org/10.1093/cid/civ263.
16. Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS. 2009. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis 48:856-862. https://doi.org/10.1086/597262.
17. Pant Pai N, Balram B, Shivkumar S, Martinez-Cajas JL, Claessens C, Lambert G, Peeling RW, Joseph L. 2012. Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet Infect Dis 12:373-380. https://doi.org/10.1016/S1473-3099(11)70368-1.
18. Luo W, Masciotra S, Delaney KP, Charurat M, Croxton T, Constantine N, Blattner W, Wesolowski L, Owen SM. 2013. Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort. J Clin Virol 58 Suppl 1:e113-e118. https://doi.org/10 .1016/j.jcv.2013.08.017.
19. Curlin ME, Gvetadze R, Leelawiwat W, Martin M, Rose C, Niska RW, Segolodi TM, Choopanya K, Tongtoyai J, Holtz TH, Samandari T, McNicholl JM, for the OraQuick Study Group. 20 March 2017. Analysis of false-negative HIV rapid tests performed on oral fluid in 3 international clinical research studies. Clin Infect Dis. https://doi.org/10.1093/cid/ cix228.
20. Centers for Disease Control and Prevention, Association of Public Health Laboratories. 27 June 2014. Laboratory testing for the diagnosis of HIV infection: updated recommendations. http://stacks.cdc.gov/view/cdc/ 23447. Accessed 9 May 2014.
21. Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, Shepherd A, Wilson P, Dahl CA, Buchsbaum S, Moeller G, Hay Burgess DC. 2006. Requirements for high impact diagnostics in the developing world. Nature 444(Suppl 1):S73-S79. https://doi.org/10.1038/nature05448.
22. Rafael ME, Taylor T, Magill A, Lim YW, Girosi F, Allan R. 2006. Reducing the burden of childhood malaria in Africa: the role of improved diagnostics. Nature 444(Suppl 1):S39-S48. https://doi.org/10.1038/ nature05445.
23. Centers for Disease Control and Prevention. 2017. Rapid influenza diagnostic tests. Centers for Disease Control and Prevention, Atlanta, GA. https://www.cdc.gov/flu/professionals/diagnosis/clinician-guidance-ridt.htm. Accessed 4 May 4 2017.
24. Lean WL, Arnup S, Danchin M, Steer AC. 2014. Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis. Pediatrics 134: 771-781. https://doi.org/10.1542/peds.2014-1094.
25. Stewart EH, Davis B, Clemans-Taylor BL, Littenberg B, Estrada CA, Centor RM. 2014. Rapid antigen group A streptococcus test to diagnose pharyngitis: a systematic review and meta-analysis. PLoS One 9:e111727. https://doi.org/10.1371/journal.pone.0111727.
26. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. 2012. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 55:1279-1282. https://doi.org/10.1093/cid/cis847.
27. Bell J, Bonner A, Cohen DM, Birkhahn R, Yogev R, Triner W, Cohen J, Palavecino E, Selvarangan R. 2014. Multicenter clinical evaluation of the novel Alere i Influenza A&B isothermal nucleic acid amplification test. J Clin Virol 61:81-86. https://doi.org/10.1016/j.jcv.2014.06.001.
28. Cohen DM, Russo ME, Jaggi P, Kline J, Gluckman W, Parekh A. 2015. Multicenter clinical evaluation of the novel Alere i Strep A isothermal nucleic acid amplification test. J Clin Microbiol 53:2258-2261. https:// doi.org/10.1128/JCM.00490-15.
29. Binnicker MJ, Espy MJ, Irish CL, Vetter EA. 2015. Direct detection of Influenza A and B viruses in less than 20 minutes using a commercially available rapid PCR assay. J Clin Microbiol 53:2353-2354. https://doi.org/ 10.1128/JCM.00791-15.
30. Uhl JR, Patel R. 2016. Fifteen-minute detection of Streptococcus pyogenes in throat swabs by use of a commercially available point-of-care PCR assay. J Clin Microbiol 54:815. https://doi.org/10.1128/JCM.03387-15.
31. Martinez AW, Phillips ST, Whitesides GM. 2008. Three-dimensional microfluidic devices fabricated in layered paper and tape. Proc Natl Acad Sci U S A 105:19606-19611. https://doi.org/10.1073/pnas.0810903105.
32. Nemiroski A, Christodouleas DC, Hennek JW, Kumar AA, Maxwell EJ, Fernández-Abedul MT, Whitesides GM. 2014. Universal mobile electrochemical detector designed for use in resource-limited applications. Proc Natl Acad Sci U S A 111:11984-11989. https://doi.org/10.1073/pnas .1405679111.
33. Granato PA, Alkins BR, Yen-Lieberman B, Greene WH, Connolly J, Buchan BW, Ledeboer NA. 2015. Comparative evaluation of AmpliVue HSV 1-2 Assay with ELVIS culture for detecting herpes simplex virus 1 (HSV-1) and HSV-2 in clinical specimens. J Clin Microbiol 53:3922-3925. https:// doi.org/10.1128/JCM.01905-15.
34. Lucchi NW, Gaye M, Diallo MA, Goldman IF, Ljolje D, Deme AB, Badiane A, Ndiaye YD, Barnwell JW, Udhayakumar V, Ndiaye D. 2016. Evaluation of the Illumigene malaria LAMP: a robust molecular diagnostic tool for malaria parasites. Sci Rep 6:36808. https://doi.org/10.1038/srep36808.
35. Pritt BS, Patel R, Kirn TJ, Thomson RB. 2016. Point-counterpoint: a nucleic acid amplification test for Streptococcus pyogenes should replace antigen detection and culture for detection of bacterial pharyngitis. J Clin Microbiol 54:2413-2419. https://doi.org/10.1128/JCM.01472-16.
36. Schreckenberger PC, McAdam AJ. 2015. Point-counterpoint: large multiplex PCR panels should be first-line tests for detection of respiratory and intestinal pathogens. J Clin Microbiol 53:3110-3115. https://doi.org/ 10.1128/JCM.00382-15.
37. Kapasi AJ, Dittrich S, González IJ, Rodwell TC. 2016. Host biomarkers for distinguishing bacterial from non-bacterial causes of acute febrile illness: a comprehensive review. PLoS One 11:e0160278. https://doi.org/10 .1371/journal.pone.0160278.
38. Herberg JA, Kaforou M, Wright VJ, Shailes H, Eleftherohorinou H, Hoggart CJ, Cebey-López M, Carter MJ, Janes VA, Gormley S, Shimizu C, Tremoulet AH, Barendregt AM, Salas A, Kanegaye J, Pollard AJ, Faust SN, Patel S, Kuijpers T, Martinón-Torres F, Burns JC, Coin LJ, Levin M, IRIS Consortium. 2016. Diagnostic test accuracy of a 2-transcript host RNA signature for discriminating bacterial vs viral infection in febrile children. JAMA 316:835-845. https://doi.org/10.1001/jama.2016.11236.